A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio
Mulholland, P. J. Brown, N. F. McBain, Catherine A Brazil, L. Peoples, S. Jefferies, S. Harris, F. Plaha, P. Vinayan, A. Brooks, C.
Mulholland, P. J.
Brown, N. F.
McBain, Catherine A
Brazil, L.
Peoples, S.
Jefferies, S.
Harris, F.
Plaha, P.
Vinayan, A.
Brooks, C.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Mulholland PJ, Brown NF, McBain C, Brazil L, Peoples S, Jefferies S, et al. A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio. Journal of Clinical Oncology. 2023 Jun;41(17). PubMed PMID: WOS:001043181100019.